RxDoctor Payments Data

Catherine Chao, MD

Pediatric Gastroenterology · Fairfax, VANPI 1184697443

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Sanofi at 27.5% of the total.

$493in general payments, 2019–2025

Across 11 payments — averaging $44.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$136
  • Regeneron Healthcare Solutions, Inc.$134
  • Pfizer$87
  • Bristol Myers Squibb$55
  • Laborie Medical Technologies Corp.$42
  • AbbVie$25
  • plus $14 from 1 others
$22,878in research payments, 2019–2025

Across 17 payments — averaging $1345.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$22K
  • AbbVie$745

What the payments were for

  • Food & beverage$493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$493 in reported general payments places this provider in the 55th percentile of 43 pediatric gastroenterology providers in Virginia.

See all pediatric gastroenterology providers in Virginia

Medicare billing

Part B allowed, 2024
$1,937
Medicare patients
15
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric gastroenterology in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →